902 related articles for article (PubMed ID: 1828842)
41. Hypercoagulability and DIC in high-risk infants.
Suzuki S; Morishita S
Semin Thromb Hemost; 1998; 24(5):463-6. PubMed ID: 9834014
[TBL] [Abstract][Full Text] [Related]
42. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
43. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract][Full Text] [Related]
44. [Coagulation-fibrinolytic abnormality and symptomatic vasospasm in the acute stage of ruptured cerebral aneurysms--analysis of alpha 2 PI, alpha 2 PIC, FDP and D.dimer].
Shibahashi H; Yamaura A
No To Shinkei; 1991 Mar; 43(3):239-46. PubMed ID: 1830749
[TBL] [Abstract][Full Text] [Related]
45. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections.
Asakura H; Wada H; Okamoto K; Iba T; Uchiyama T; Eguchi Y; Kawasugi K; Koga S; Mayumi T; Koike K; Gando S
Thromb Haemost; 2006 Feb; 95(2):282-7. PubMed ID: 16493490
[TBL] [Abstract][Full Text] [Related]
47. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
48. [Fibrin monomer assay].
Kobayashi H; Matsuo M; Ikeguchi K; Yamamoto K; Kario K; Matsuo T
Rinsho Byori; 1991 Jul; 39(7):689-93. PubMed ID: 1920860
[TBL] [Abstract][Full Text] [Related]
49. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
[TBL] [Abstract][Full Text] [Related]
50. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
51. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
Seo JW; Kim HK; Kim JE; Park S; Cho HI
Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
[TBL] [Abstract][Full Text] [Related]
52. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
53. Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation.
Chung S; Kim JE; Kim JY; Lee DS; Han KS; Kim HK
Thromb Res; 2010 Jun; 125(6):e285-93. PubMed ID: 20185166
[TBL] [Abstract][Full Text] [Related]
54. [Diagnosis of predictive state of disseminated intravascular coagulation].
Yamamoto K; Saito H
Nihon Rinsho; 1993 Jan; 51(1):74-8. PubMed ID: 8433531
[TBL] [Abstract][Full Text] [Related]
55. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
Okajima K; Sakamoto Y; Uchiba M
Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
[TBL] [Abstract][Full Text] [Related]
56. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
[TBL] [Abstract][Full Text] [Related]
57. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin.
Dickneite G; Czech J; Keuper H
Circ Shock; 1994 Apr; 42(4):183-9. PubMed ID: 8055664
[TBL] [Abstract][Full Text] [Related]
58. Coagulation/fibrinolysis disorder in patients with severe preeclampsia.
Kobayashi T; Tokunaga N; Sugimura M; Suzuki K; Kanayama N; Nishiguchi T; Terao T
Semin Thromb Hemost; 1999; 25(5):451-4. PubMed ID: 10625201
[TBL] [Abstract][Full Text] [Related]
59. [Diagnosis of DIC based on evidence].
Wada H; Nishioka J; Nobori T; Sakaguchi A; Abe Y
Rinsho Byori; 2006 Nov; 54(11):1172-7. PubMed ID: 17240840
[TBL] [Abstract][Full Text] [Related]
60. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
